Just because of Health Reform? Pharmaceutical Companies Suddenly Cut Investments in Germany
16 Articles
16 Articles
The pharmaceuticals industry stands up against planned cuts – and even cuts investments in Germany. Politicians are outraged. Does the government still kick in?
Within a few hours, two pharmaceutical companies cancel or cancel investments in Germany. An expert sees this in a wider context and chooses clear words.
kreiszeitung.de
op-online.deTwo well-known pharmaceutical companies from Germany and abroad withdraw their investment plans in Germany and place the blame on the Federal Government. This is now impressive.
The pharmaceutical companies Boehringer Ingelheim and Eli Lilly have announced the stoppage of high investments in Germany and justify this with savings targets from Berlin. Now the Federal Government expresses itself.
It is another Job's message for the new black and red state government in Rhineland-Palatinate. Only now has the pharmaceutical company Boehringer announced in Ingelheim to cut its planned investments in Rhineland-Palatinate. Now the US pharmaceutical company Lilly wants to do this in Alzey. The state government has to overcome the first major crisis just a few weeks after its oath. May 2025: Best mood on the construction site of the US pharmace…
After Boehringer Ingelheim and Eli Lilly cut investments in Germany, the federal government faced criticism. Health Minister Warken responded that the criticized austerity measures were also in the interest of the pharmaceutical companies.
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
